Related references
Note: Only part of the references are listed.Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy
Sourina Pal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Advances in immune checkpoint inhibitors for bone sarcoma therapy
Pichaya Thanindratarn et al.
JOURNAL OF BONE ONCOLOGY (2019)
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome
Eva Hlavackova et al.
FRONTIERS IN ONCOLOGY (2019)
Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment
Katerina Pilatova et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part Sarcoma
Jeremy Lewin et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Low-dose cyclophosphamide depletes circulating naive and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy
Lisanne Noordam et al.
ONCOIMMUNOLOGY (2018)
The level of myeloid-derived suppressor cells positively correlates with regulatory T cells in the blood of children with transient hypogammaglobulinaemia of infancy
Izabela Sieminska et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Enhancing adoptive cancer immunotherapy with VΥ2Vδ2 T cells through pulse zoledronate stimulation
Mohanad H. Nada et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
Kalijn F. Bol et al.
ONCOIMMUNOLOGY (2016)
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
Kalijn F. Bol et al.
CLINICAL CANCER RESEARCH (2016)
Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
Melinda S. Merchant et al.
CLINICAL CANCER RESEARCH (2016)
Biologic Activity of Autologous, Granulocyte-Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines
John M. Goldberg et al.
CLINICAL CANCER RESEARCH (2015)
Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
Erik H. J. G. Aarntzen et al.
CLINICAL CANCER RESEARCH (2013)
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity
Dieter Kabelitz et al.
ONCOIMMUNOLOGY (2013)
Paediatric Reference Values for the Peripheral T cell Compartment
E. J. H. Schatorje et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Impact of tumour volume on the potential efficacy of therapeutic vaccines
J. L. Gulley et al.
Current Oncology (2011)
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
Crystal L. Mackall et al.
CLINICAL CANCER RESEARCH (2008)
How regulatory T cells work
Dario A. A. Vignali et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer
A. M. Dohnal et al.
CYTOTHERAPY (2007)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The TCR δ repertoire in normal human skin is restricted and distinct from the TCR δ repertoire in the peripheral blood
V Holtmeier et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Share Paper
